Over a period of five years, antemortem diagnosis of leptomeningeal spread was made in six of thirteen children with high grade astrocytomas. These included four of seven children with hemispheral tumors and two of six children with malignant brainstem gliomas. Leptomeningeal spread was diagnosed by the clinical picture and CSF profile. Meningeal spread occurred an average of 5 months (range 0-16) after initial diagnosis of tumor was made. Several patients responded well to local radiation and/or chemotherapy. Mean survival after evidence of meningeal spread was 7 months (range 2 16) with one patient still alive.
Introduction

Materials and methods
Glioblastoma multiforme is a malignant brain tumor of glial origin with rapid growth and a fatal course. The tumor comprises approximately t5-20% of intracranial tumors in adults 3-11% in children (1) . Its course is characterized by rapid local extension, sometimes with meningeal involvement, but it only occasionally metastasizes via cerebrospinal-fluid (CSF) pathways. This report describes our experience with six children with malignant astrocytomas (grades III and IV) in whom spinal meningeal dissemination was diagnosed. Our data suggest that CSF metastases may be a common complication of high grade astrocytomas, and that the use of spinal irradiation or chemotherapeutic agents is of short-term benefit. * Current Address: Pediatric Neurology, University of Michigan Medical Center, Ann Arbor, MI 48109 0010, USA.
During the five year period, June 1977 to June 1982, 90 new cases of primary brain or optic nerve tumors were diagnosed in children under the age of 17 years at the Johns Hopkins Hospital pediatric neurology service. Of this group, 19 had supratentorial astrocytomas of which seven were grade III or IV based on the pathologic criteria defined by Kernohan and Sayre (2). All 19 were biopsied. Ten had brainstem gliomas of which 4 had a clinical picture and course consistent with a low grade glioma (1 confirmed by biopsy) and 6 appeared to have a grade III-IV glioma of which 3 were confirmed by biopsy or CSF cytopathology (3) .
At many institutions, it is now common to restrict the term glioblastoma multiforme to either grade IV astrocytomas or poorly differentiated anaplastic tumors of glial origin for which there is no definite evidence of a preexisting astrocytoma.
Grade III astrocytomas are often referred to as malignant or anaplastic astrocytomas. Since it is difficult to clearly distinguish between grades three and four astrocytomas on the basis of a biopsy specimen (4), these cases have been combined and represent the study population. Autopsy permission was denied.
Results
Among the thirteen children with high-grade tumors, six had clinical evidence of meningeal spread (Tables 1 and 2 , Cases 1 6). There were no known instances of meningeal spread in the twelve children with grade I and II supratentorial astrocytomas or the four children with low-grade brainstem gliomas.
Of the six cases with evidence of meningeal spread, four had primary hemispheral tumors and two had pontine gliomas. The mean age of onset was 9. ! years for the hemispheral tumors (range: 5 months-15 years) and 6.9 years for the brainstem gliomas (range: 4 9/12-9 years). Diagnoses were based on neuroradiographic studies in all cases and, in 5 of the cases, on tumor biopsy as well. Diagnosis in case 5 (not biopsied) was based on the clinical picture, CT scan and malignant tumor cells in CSF (Fig. 1A) . Meningeal spread of the primary tumor in Cases 1-6 was diagnosed by clinical symptomatology, neurological exam, CSF cytology (Fig.  1B ) and response to therapy. All but Case 5 had alterations in tone and most had diminution of reflexes. In the five cases (2-6) where a lunabar puncture or shunt tap was performed, all had abnormal CSF findings (Table 3) : cytopathology positive in 3/5, increased protein 3/5, leukocytes 3/5. In patients 2 and 3, cranial computerized tomography showed abnormal tentorial or periventricular enhancement, suggestive of CSF spread (Fig. 2) .
The mean interval between diagnosis of the primary tumor and evidence of meningeal involvement was five months (range 0-16 months). Following the diagnosis of spinal metastasis, all patients except Case 4 received either local cord irradiation, intrathecal methotrexate/thiotepa or systemic cisplatinum. Symptomatic response was noted in every case, ranging from diminution of pain to improved mobility. In the five deceased patients in whom antemortem diagnosis of meningeal spread was made, mean survival was 13 months from the diagnosis of the primary tumor (range: 3 22 months) and 7 months from onset of myelopathy or radiculopathy (range: 2 16 months). One patient (Case 5) is still alive 14 months from the diagnosis of her tumor and of CSF spread. 
Discussion
Subarachnoid dissemination of malignant astrocytoma/glioblastoma multiforme, outside the area of the primary tumor or operative site, was previously considered quite rare (5, 6) . Recently, however, two large autopsy series of 77 patients with high grade astrocytomas, reported an approximately 25% incidence of leptomeningeal metastases in patients ranging from 5 to 69 years, two of whom were children (7, 8) . In one of these series (8) eight of twelve cases were diagnosed antemortem. A small group of five patients with atypical juvenile astrocytomas and subarachnoid spread has also been reported (9) . Spinal leptomeningeal metastases originating from a pineal glioblastoma multiforme have also been reported (10) . The frequency of subarachnoid spread of malignant brainstem gliomas remains controversial. One recent pediatric autopsy series reported anatomical evidence of spread in seven of sixteen cases (11) while another series with pediatric and adult cases found only one instance of subarachnoid spread in 25 cases (12) . Finally, in a series with fifteen cases presenting as brainstem gliomas (13), five (33%) developed leptomeningeal metastases. This study differs from previous reports in that it is restricted to the pediatric population, specifically 127 children less than age 17. In our 5 year period of analysis none of the twelve patients with grade one or two supratentorial astrocytomas nor the four patients with low-grade brainstam gliomas showed clinical evidence of subarachnoid spread. However, six out of thirteen cases of malignant astrocytomas (grades three or four) developed signs or symptoms of spinal meningeal seeding.
For the last three years of the study, evidence of meningeal spread was systematically looked for in all patients with high grade gliomas. In our patients, there was no specific clinical pattern characteristic of leptomeningeal invasion. Findings included: stiff neck, back pain, sensory loss, hypotonia, weakness, depressed or absent reflexes and decreased anal tone or bowel and bladder incontinence. These are similar to those described in adults with meningeal spread and to adults with carcinomatous meningitis (8) . Although it was sometimes difficult to determine whether these clinical findings represented meningeal spread or direct tumor extension, particularly in the case of brain stem gliomas, supportive evidence included the presence of nuchal rigidity, the CSF profile, or CT scans. As meningeal irritation may also be the result of cerebellar herniation, subarachnoid, hemorrhage, infectious meningitis or spillage of necrotic tumor material producing a chemical meningitis (14) , the analysis of CSF and cranial CT scans was helpful, especially when other findings consistent with a gliomatous meningitis .were present. Cranial CT scans demonstrated periventricular enhancement in two patients, findings supportive of a disseminated meningeal tumor. The utility of cranial CT scans in providing reliable evidence for meningeal invasion has been described (15) . Finally, the beneficial response of spinal cord signs and symptoms to local irradiation or chemotherapy has further supported the diagnosis of spinal subarachnoid spread.
The current prognosis of patients with glioblastoma multiforme is poor (16) . it has been suggested that the documentation of spinal spread is not worthwhile since the primary tumor is fatal before symptoms of spinal seeding are present (17) . In our cohort, spinal cord symptoms were the source of great discomfort and occurred months prior to death in all our cases. Significant, albeit temporary, improvements in the well-being of the patients were achieved with therapy. As newer primary che- 
